Skip to content
Disclosery

CAXTON ASSOCIATES LLP: CLOV position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CAXTON ASSOCIATES LLP on CLOV, newest first. How the timeline and the estimate are built.

CAXTON ASSOCIATES LLP held 1,216,631 CLOV shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,216,631 shares
    Change vs previous 13F +1,216,631 shares

    0.12% of the 13F portfolio, value $6,375,146.

    13F-HR 0002051323-26-000013 filed by CAXTON ASSOCIATES LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2025-06-30
    13F 0 shares
    Change vs previous 13F -445,512 shares

    13F-HR 0002051323-25-000011 filed by CAXTON ASSOCIATES LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  3. period ended2025-03-31
    13F 445,512 shares
    Change vs previous 13F not available

    0.06% of the 13F portfolio, value $1,599,388.

    13F-HR 0002051323-25-000006 filed by CAXTON ASSOCIATES LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).